Vikram Solar Targets 7.5–8 GW FY27, DCR Shift After June 2026

May 13, 2026 6 mins read Firehose Gupta

Vikram Solar Limited — Q4 & FY26 Earnings Call (May 08, 2026)

1. Overall Tone of Management: Optimistic

Management repeatedly frames FY26 as “record” and “blockbuster,” with strong confidence in a “multi-year trajectory.”
Uses assertive, forward-looking language: “direction is clear,” “the demand environment is the strongest and most durable,” and “we plan to deliver approx. 7.5 to 8 gigawatts in FY27.”
Acknowledges some cost pressure (EVA, aluminum, crude oil) but emphasizes mitigation via pass-through and scale.

2. Key Themes from Management Commentary

Structural demand shift in India: Solar growth is described as policy- and energy-security-driven rather than a “price cycle risk.”
Backward integration as the core strategy: Roadmap “modules first, then cell, then wafer and ingot,” targeting full integration “from ingot to module.”
BESS as the next growth frontier: Policy-anchored and “margin-accretive,” with a stated target of 15 GWh by FY30.
Execution credibility / ramp capability:
Vallam module plant: “ideation to commissioning in under nine months.”
Gangaikondan module and TOPCon cell: detailed commissioning timeline through Q4 FY27 / early FY28 ramp.
Financial strength enabling capex:
“no long-term debt,” compressed working capital cycle (82 → 44 days).
Emphasis on operating leverage and margin expansion in FY26.
DCR transition management:
Non-DCR dominates near-term; DCR demand ramps post June 2026.
They positioned a 2 GW domestic cell procurement to participate in DCR.

3. Q&A Analysis

Theme A: DCR rollout timing & order book reporting

Core questions
When will DCR module rollout begin from the 2 GW cell procurement?
Why were “distribution” orders removed from order book / how will DCR vs Non-DCR mix evolve?
Is there any DCR volume in the current quarter?
Management response
Procurement phased to cover DCR demand “post the June 2026 deadline,” with “entire offtake… within FY27” and “ballooned offtake in H2.”
Distribution order book format changed due to DCR shift and outsourced cell supplies; distribution now treated as “spot buying” rather than recurring order book.
DCR volume in the quarter: “hardly any volume.”
Non-DCR will persist only via “grandfathered projects of 87 gigawatts”; “rest everything will move to DCR.”
Notable / evasive elements
Pricing/spread details for the 2 GW procurement were not disclosed (see Theme C).

Theme B: Capex planning, phasing, and changes in sourcing

Core questions
Capex differential: machinery procurement “directly from China vs Thailand.”
Capex schedule for FY27/FY28 across cell, BESS, and wafer-ingot.
Management response
China sourcing change: “10% cost increase.”
Cell capex for 12 GW: ~₹5,400 crores, with most deployment in FY26/FY27 window; “last 10% instalment… spill over to FY28.”
BESS:
- 5 GWh assembly: ~₹150 crores, “majorly in the current year.”
- Cell manufacturing: construction starts “October 26,” 24-month period; FY27 mostly land/initial expenses “not more than ₹200 crores.”
Wafer-ingot:
- First 6 GW phase commissioning: “March 28,” construction start “Q2/Q3,” initial advances “within ₹100 crores.”
- Remaining 6 GW: “thumb rule of about ₹600 crores per gigawatt,” Board approval in subsequent year.
Notable / evasive elements
No granular breakdown by quarter; answers were high-level but specific on totals and timing.

Theme C: Margins / realization pressure and pass-through

Core questions
What drove gross margin contraction / realization decline (module realization down ~13% mentioned by analyst)?
Where will realizations land in the coming year?
For the 2 GW procurement: any finalized pricing/spread?
Management response
Q4 per-watt-peak: realizations “gone up… by about INR0.60,” costs up “by INR0.80,” net impact “INR0.20” denting per-unit EBITDA.
They expect “some more rationalization” in coming quarters; absolute numbers expected to increase with scale.
Procurement commercials: “unwise… to share the commercials,” but they “assure” EBITDA per watt-peak expectation is maintained.
Notable / evasive elements
Procurement economics were partially withheld; they provided a qualitative assurance only.

Theme D: BESS policy/localization economics

Core questions
How will BESS localization policy work (including DCR-linked localization targets)?
How much localization can be achieved via assembly only?
Management response
“Extremely optimistic” on policy mandate; expects additional policy on “Approved List of Battery Manufacturers.”
Mentions Advanced Chemistry PLI and viability gap funding ~₹18,000 crores, with BESS tender pipeline “about 100 GWh” in various RFP/bid stages.
No hard numbers on localization achievable via assembly alone; stayed qualitative and policy-driven.

Theme E: Debt levels, interest expense, and capex funding

Core questions
Earlier plan: ₹3,500 crores debt by end FY27—does phasing change this?
Will bottom-line be pressured by interest expense (~₹500–₹800 crores) despite topline/EBITDA growth?
Management response
Debt plan adjusted due to phasing: FY27 closing debt considered ~₹3,200 crores (12 GW cell phased to 9+3).
FY28 wafer-ingot capex: ₹6,500–6,600 crores.
Interest expense: they argued interest during capex is “capitalized,” not charged to P&L; P&L impact comes when assets commission (FY29 wafer-ingot, March 27 cell).
Notable / evasive elements
They did not directly confirm the analyst’s exact interest-to-P&L mapping; relied on capitalization mechanics.

Theme F: Production/sales strategy and utilization

Core questions
Expected FY27 production vs FY26; how will the 8.2 GW order book be executed?
Utilization levels for modules/cells.
Management response
FY27 production: “some 8 gigawatts,” with 2 GW DCR and 6 GW non-DCR.
Order book execution logic: 8.2 GW as of Mar 31, 2026; 7.2 domestic; 6 GW aligned as discussed; remaining 1.2 used to capture grandfathered Non-DCR.
Utilization: modules 65–70% nameplate; cells 70–75% nameplate.
Notable / evasive elements
No explicit unit economics by segment (IPP vs C&I vs rooftop) beyond broad margin targets.

4. Guidance / Outlook

Explicit guidance (quantitative)

FY27 capacity / financial targets
“deliver approx. 7.5 to 8 gigawatts in FY27”
“EBITDA about 74% more than… FY26… range of ₹1,500 to ₹1,600 crores”
BESS
Target: “15 gigawatt-hours of BESS capacity by FY30”
Integration / commissioning milestones
Gangaikondan module: first output “on track for June 2026”
TOPCon cell: first cell out “end December / early January”; sequential commissioning through “March 2027”; ramp in “Q2 FY28”
Wafer-ingot: first phase 6 GW commissioning “FY29” (construction start Q2/Q3; first phase commissioning March 28 referenced in Q&A)
Margin targets (qualitative-to-quantitative)
Non-DCR FY27 expected EBITDA per watt-peak: “INR1.75 to INR2”
After integration: FY28 expected EBITDA per watt-peak: “about INR5 per watt peak” (and “trim down by 1 more rupee in FY28”)

Implicit signals (qualitative)

Demand durability: management asserts “strongest and most durable” demand environment.
DCR ramp confidence: expects DCR demand to rise to “20 to 25 gigawatts” (analyst question; management provided numbers).
Margin resilience via structure:
“~80% of order book carries cell price pass-through clauses”
Emphasis on per-watt-peak EBITDA discipline rather than headline gross margin.

5. Standout Statements (direct / highly revealing)

Structural risk framing: “energy dependence is now a structural risk, not a price cycle risk.”
Strategic positioning: “Solar is no longer being pulled by incentives; it is being pushed by policy… and by energy security.”
Integration end-state: “By the end of this roadmap, Vikram Solar will be fully integrated from ingot to module.”
BESS growth target: “Our target is 15 gigawatt-hours of BESS capacity by FY30.”
Execution proof point: Vallam “from ideation to commissioning in under nine months.”
Order book visibility: “Order book stands at 8.2 gigawatts as on 31st March 2026.”
Margin mechanics: “~80% of our order book carries cell price pass-through clauses.”
FY27 EBITDA guidance: “range of 1,500 to 1,600 crores.”
Procurement economics withheld: “unwise for us to share the commercials” (for 2 GW DCR cell procurement).

6. Red Flags / Positive Signals

Positive signals
– Strong balance sheet: “no long-term debt,” net working capital improved to 44 days.
– Clear capex phasing and commissioning timelines with operational detail.
– Pass-through protection: “80%… cell price pass-through clauses.”
– Concrete FY27 EBITDA and capacity guidance.

Red flags
– Several answers rely on capitalization and “capital prudence” without fully quantifying near-term P&L impacts (interest expense discussion).
– Procurement economics for DCR cell supply were not disclosed; reliance on “EBITDA per watt-peak maintained” without numbers.
– Margin outlook uses per-watt-peak targets that may be sensitive to industry pricing and utilization; management assumes rationalization and scale benefits.

7. Historical Comparison & Consistency Analysis

Limitation: No prior earnings call transcripts were provided (“No documents matched the configured filters”). Therefore, I cannot perform a true multi-period consistency/credibility comparison, tracking of past commitments vs outcomes, or narrative shifts across prior calls.

If you share the previous 3–4 transcripts, I will produce the requested:
– change in tone over time,
– delivered/delayed/missed commitments,
– narrative shifts,
– credibility scoring,
– theme evolution and cross-period red flags.